comparemela.com

Piotr Musialek News Today : Breaking News, Live Updates & Top Stories | Vimarsana

InspireMD, Inc (NASDAQ:NSPR) Q3 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the InspireMD Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Marvin slosmanBenjamin haynorPiotr musialekBen haynorChuck padalaExchange commissionInspiremd incAlliance global partnersDrug administrationCall transcript novemberChief executive officerCraig shoreChief financialChief executiveProfessor piotr musialekAlliance global

InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update

09.08.2022 - - Generated 47.8% growth in CGuard revenue year-over-year - - Delivered several presentations at LINC 2022 featuring CGuard EPS, including a successful live case transmission - - Announced that endovascular pioneer Dr. Juan Parodi .

United statesMarvin slosmanPiotr musialekJuan parodiChuck padalaExchange commissionCompany annual report on formInspiremd incDrug administrationCompany quarterly report on formHost investor conference call todayEmbolic prevention systemRecent highlightsC guardian investigational device exemptionProfessor piotr musialekJohn paul

Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)

/PRNewswire/ Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the treatment of ischemic.

Tel avivTsipi haitovskyItzhak orionPiotr musialekAsger andersenBenny dilmoneyPulmonary embolism response teamAarhus university hospitalMagneto thrombectomy solutionsBiomed israelLife sciencePeregrine venture incubatorTechnology transfer companyBen gurion universityPeregrine venturesJohn paul

Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)

/PRNewswire/ Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the treatment of ischemic.

Tel avivTsipi haitovskyItzhak orionPiotr musialekAsger andersenBenny dilmoneyPulmonary embolism response teamAarhus university hospitalMagneto thrombectomy solutionsBiomed israelLife sciencePeregrine venture incubatorTechnology transfer companyBen gurion universityPeregrine venturesJohn paul

Magneto Thrombectomy Solutions eTrieve Catheter for PE Evaluated in FIH Study in Europe

May 10, 2022—Magneto Thrombectomy Solutions, an Israel-based medical device company developing thrombectomy solutions for the treatment of ische

United statesTel avivItzhak orionPiotr musialekAsger andersenBenny dilmoneyAarhus university hospitalBen gurion university of the negev in beershebaMagneto thrombectomy solutionsBiomed israelLife sciencePrincipal investigatorProfessor piotr musialekJohn paulPeregrine ventureChief technical officer

vimarsana © 2020. All Rights Reserved.